SciELO - Scientific Electronic Library Online

 
vol.75 issue6Hybrid Therapies for Supporting Critically Ill Patients with Acute Kidney Injury: When, how, and for Whom?Adsorptive Therapies in Sepsis and Inflammation: Description of the Various Adsorptive Techniques and their Failure to Improve Outcomes author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de investigación clínica

On-line version ISSN 2564-8896Print version ISSN 0034-8376

Abstract

GALINDO, Pablo  and  NEYRA, Javier A.. Continuous Renal Replacement Therapy: What Have We Learned And What Are Key Milestones For The Years To Come?. Rev. invest. clín. [online]. 2023, vol.75, n.6, pp.348-358.  Epub Mar 12, 2024. ISSN 2564-8896.  https://doi.org/10.24875/ric.23000221.

Continuous renal replacement therapy (CRRT) is the main extracorporeal kidney support therapy used in critical ill patients in the intensive care unit (ICU). Since its conceptualization ~50 years ago, there have been major improvements in its technology and utilization. The last decade, and particularly since the COVID-19 pandemic, has been marked by a growing interest and demand of CRRT in worldwide ICUs. This has underpinned the need for improvements in nomenclature and process standardization, optimization of CRRT deliverables, and the development and validation of key performance indicators. Further, how to leverage digital health technologies to build clinical decision support for CRRT and improve personalized bedside decisions is a subject of intense investigation. Herein, we summarize notable advancements in the provision of CRRT and propose areas in need of further development.

Keywords : Continuous renal replacement therapy; Technological advances; Therapy deliverables; Prescription standardization; Artificial intelligence; Challenges.

        · text in English     · English ( pdf )